Form 4: Doximity CFO Anna Bryson Executes Stock Transactions Under 10b5-1 Plan

Doximity's Chief Financial Officer, Anna Bryson, executed multiple transactions involving the company's Class A and Class B common stock, including conversions, sales, and option exercises, under a pre-arranged 10b5-1 trading plan.

Summary

• Anna Bryson, the Chief Financial Officer of Doximity, Inc., engaged in several transactions involving the company's stock on November 12, 2024.
• These transactions included the conversion of 100,000 shares of Class B Common Stock into Class A Common Stock.
• Ms. Bryson also sold a total of 100,000 shares of Class A Common Stock at weighted average prices ranging from $57.8313 to $59.7449 per share.
• These sales were executed automatically under a Rule 10b5-1 trading plan adopted on November 30, 2023.
• Additionally, Ms. Bryson exercised stock options for 100,000 shares of Class B Common Stock, which were then converted to Class A Common Stock.
• Following these transactions, Ms. Bryson's direct holdings of Class A Common Stock decreased to 304,506 shares.

Sentiment

Score: 6

Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither particularly positive nor negative. The sales are expected and do not indicate any significant change in the company's outlook.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating a planned and transparent approach to stock sales.
• The conversion of Class B shares to Class A shares simplifies the capital structure.

Negatives

• The sale of 100,000 shares by the CFO could be perceived negatively by some investors, although it is part of a pre-planned strategy.

Risks

• The market may react negatively to the sale of shares by a key executive, even if it is part of a pre-planned trading plan.
• Fluctuations in the stock price could impact the value of the remaining shares held by the CFO.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, such as those in the technology and healthcare sectors, to manage their stock sales.
• Similar filings are regularly made by executives at companies like Teladoc Health, Veeva Systems, and athenahealth, which are also in the healthcare technology space.
• The volume of shares sold and the price range are within the typical range for executive stock transactions.

Stakeholder Impact

• Shareholders may be interested in the stock transactions of key executives, but the pre-planned nature of these sales should mitigate any negative impact.
• Employees may view the transactions as part of the normal course of business for executive compensation.

Key Dates

Keywords

Doximity, Anna Bryson, SEC Form 4, insider trading, stock transactions, Rule 10b5-1, Class A Common Stock, Class B Common Stock, stock options, CFO